Get it on Google Play

Antibody Cocktail Treatment For Covid

Antibody Cocktail Treatment For Covid:

Doctors from Sir Ganga Ram Hospital in New Delhi have successfully analysed the monoclonal antibody therapy on two Covid-19 patients. This therapy resulted into fast progression of symptoms within first seven days.

About the therapy:

  • Two patients were administered REGCov2 (Casirivimab and Imdevimab). They started to produce resistance against SARS-CoV-2, recovered, and then discharged within 12 hours of administration of doses.
  • A healthcare worker with high-grade fever, cough, myalgia, severe weakness, and leucopenia was administered REGCov2 on day six of the disease, according to the press release of the hospital.
  • This “antibody cocktail treatment” for coronavirus has the potential to prevent case escalation from mild to severe, which requires hospitalization in 70% of cases.
  • This therapy is most suited for “high-risk Covid-19 patients” in the first 10 days of symptom onset and who meet any of the listed criteria like age being 65 years or above.

Monoclonal Antibodies:

  • Monoclonal antibodies are identical copies of antibody that targets one specific antigen.
  • They are made by cloning a unique white blood cell.
  • All subsequent antibodies which are derived this way belong to a unique parent cell. Monoclonal antibodies have a monovalent affinity.
  • They bind only to the same epitope which is part of an antigen recognized by antibody)

Leave a Reply

Your email address will not be published. Required fields are marked *